News

DelveInsight's Cancer Cachexia Market Insights report includes a comprehensive understanding of current treatment practices, cancer cachexia emerging drugs, market share of individual therapies, and ...
Several customers' critical information has been compromised, leading to data breach alerts issued by JPMorgan Chase, Bank of America, and TD Bank.
Sangsangin Savings Bank faces uncertainty after Dong Sung Bio Pharms rehab filing Sangsangin Savings Banks investment in Dong Sung Bio Pharm raises questions amid financial turmoil.
Bank of Ireland has issued a warning over what it calls a dramatic increase in reports and cases of attempted so-called 'safe account' scams. The lender is advising customers to be "on particular ...
BIO-key and Runlevel have already secured their first customer in the region — a National Bank in Mozambique — which is deploying a comprehensive suite of BIO-key’s biometric-based IAM ...
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comSAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Belite Bio ...
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative ...
Bio-Rad Laboratories (NYSE:BIO – Free Report) had its target price decreased by Royal Bank of Canada from $409.00 to $392.00 in a research note published on Friday morning,Benzinga reports ...
The recent failures of Silicon Valley Bank and Signature Bank have many Americans concerned about the economy and the safety of their money. Although the government has stepped in to contain the ...
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co recently entered into an agreement with the Bank of China to subscribe to a structured deposit product worth RMB200 million.
Boca Raton, Florida, Dec. 10, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments ...